首页 | 本学科首页   官方微博 | 高级检索  
检索        

肝门部胆管癌外科治疗20年经验回顾
引用本文:郑树国,何振平,董家鸿,王曙光,别平,蔡景修,韩本立,李智华,黄志强,刘永雄.肝门部胆管癌外科治疗20年经验回顾[J].中国普通外科杂志,2001,10(1):6-10.
作者姓名:郑树国  何振平  董家鸿  王曙光  别平  蔡景修  韩本立  李智华  黄志强  刘永雄
作者单位:1. 第三军医大学西南医院肝胆外科, 重庆400038
2. 解放军总医院肝胆外科, 北京100853
摘    要:目的 总结20年肝门部胆管癌外科治疗的经验,探讨提高切除率,减少并发症的有效措施。方法 回顾总结1978年1月-1997年12月西南医院外科治疗201例肝门部胆管癌的临床资料,以1991年为界限前后分为两个阶段以对照手术切除率、并发症及死亡率等。结果 201例中手术切除97例,非切除行胆道内、外引流者84例,单纯剖腹探查20例。切除组中根治切除51例,姑息切除46例。随访75例中,根治切除者1,3,5年生存率分别为95.45%,40.91%,13.64%;姑息切除者1,3年生存率为55%,10%,无5年生存者;非切除性胆道内、外引流者1年生存率为36%,无3年生存者;单纯剖腹探查者均于3个月内死亡。两个阶段对照显示:手术切除率由1990年12月以前的34.95%提高到以后的62.24%,其中根治切除率由15.53%提高到35.71%;手术并发症及死亡率分别由39.8%和17.84%降低到18.37%和6.12%。结论 根治切除是提高肝门部胆管癌远期存活率的关键,合理的围手术期处理可工发症发生率及死亡率。

关 键 词:胆管肿瘤  腺癌  外科手术  治疗  胆管癌
文章编号:1005-6947(2001)01-0006-05

Twenty-year experience in surgical treatment of hilar cholangiocarcinoma
ZHENG Shu guo ,HE Zhen ping ,DONG Jia hong ,WANG Shu guang ,BIE Ping ,CAI Jing xiu ,HAN Ben li ,LI Zhi hua ,HUANG Zhi qian ,LIU Yong xong.Twenty-year experience in surgical treatment of hilar cholangiocarcinoma[J].Chinese Journal of General Surgery,2001,10(1):6-10.
Authors:ZHENG Shu guo  HE Zhen ping  DONG Jia hong  WANG Shu guang  BIE Ping  CAI Jing xiu  HAN Ben li  LI Zhi hua  HUANG Zhi qian  LIU Yong xong
Institution:ZHENG Shu guo 1,HE Zhen ping 1,DONG Jia hong 1,WANG Shu guang 1,BIE Ping 1,CAI Jing xiu 1,HAN Ben li 1,LI Zhi hua 1,HUANG Zhi qian 2,LIU Yong xong 2
Abstract:Objective To summarize twenty year experience in the surgical treatment of hilar cholangiocarcinoma(H CC) and explore the effective measuers for increase in resectional rate and reducing operative morbidity and mortality of H CC. Methods Clinicopathological data of 201 patients with H CC treated surgically in our center between 1978 and 1997 were analysed retrospectively. The resection rate, operative morbidity and mortality of the patients before and after December 1990 were compared. Results Of the 201 patients, 97 underwent resection(redical resection in 51; palliative in 46), 84 subjected to internal or external drainage and 20 only laparotomy. In 75 followed up patients, the 1,3,5 year survival rate was 95.45%, 40.91%, 13.64% in radical resection group, and 55%, 10%, 0% in palliative resection group respectively; whereas in unresectional internal and external drainage group, 1 year survival rate was 36%, noone survived for more than 3 years. All the patients with only laparotomy died within 3 months after operation. Comparation of the two stages revealed that the resection rate had been increased from 34.95% before December 1990 to 62.24% after December 1990, and the radical resection rate from 15.53% to 35.71%, meanwhile the operative morbidity and mortality decreased from 39.80% and 17.84% to 18.37% and 6.12% respectively. Conclusions Radical resection plays an important role for improving long term survival rate in patients with H CC. Appropriately perioperative care can reduce the operative morbidity and mortality.
Keywords:BILE DUCT NEOPLASMS/surg  ?HEPATIC DUCT  COMMON/surg  ?ADENOCARCINOMA/surg
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号